The Novartis Malaria Initiative Der Weg zur Eliminierung von Malaria Silvio Gabriel, BASAID April 2012.

Slides:



Advertisements
Similar presentations
Health Doing Business with the World - The new role of corporate leadership in global development Geneva, September 2007 World Business Council for Sustainable.
Advertisements

"Eliminating HIV Mother to Baby Transmission: A Status Report on Perinatal HIV in Florida " Ana M. Puga, MD- Medical Director Comprehensive Family AIDS.
If our class were an exact representation of the World, then….. 60% of the students would be Asian 14% of the students would be African 12% of the students.
UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
UNDP RBA MDG-Based National Planning Workshop
MICS3 Data Analysis and Report Writing
MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop Household Questionnaire: Insecticide Treated Nets and Indoor Residual.
THE 2004 LIVING CONDITIONS MONITORING SURVEY : ZAMBIA EXTENT TO WHICH GENDER WAS INCORPORATED presented at the Global Forum on Gender Statistics, Accra.
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
How Gender Impacts Safe Motherhood
9th Advanced HIV Course Aix-en-Provence 2011 Role of ARV as Prevention Martin Fisher Brighton and Sussex University Hospitals, UK.
1 TREATMENT AND PREVENTION SCALE-UP: THE SOUTH AFRICAN EXPERIENCE By Dr Moolman Team South Africa.
HIV Situation in India Dr Sunil Gaikwad.
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Ministry of Health National STD/AIDS Programme Universal Access to Antiretroviral Therapy: The Brazilian Experience.
HIV/AIDS Estimation and Projections: Overview of Methods and Activities.
1. 2 Why are Result & Impact Indicators Needed? To better understand the positive/negative results of EC aid. The main questions are: 1.What change is.
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Overview of HPV vaccination Training GardasilTM
No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.
Malaria Figures 3.3 billion people at risk of malaria in billion at high risk (>1 case/1000 population) mainly in the WHO African (49%) and South.
Who Wants To Be A Millionaire?
Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.
£1 Million £500,000 £250,000 £125,000 £64,000 £32,000 £16,000 £8,000 £4,000 £2,000 £1,000 £500 £300 £200 £100 Welcome.
Pharmaceuticals Industry Research and Development.
How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva
Monitoring the impact of vaccination on rubella and CRS Susan E. Reef, MD 11 th Annual Meeting The Measles and Rubella Initiative Sept. 19, 2012.
Background Ethiopia: second populous country in Africa, 80 million
The Global Tobacco Epidemic and WHO Tobacco Control Policies
September 18, 2013 National Housing Conference Carol Redmond Naughton.
Water is Life Clean water is most important factor in life. Thankfully, many wells are drilled. Unfortunately, there isnt a working plan to maintain them.
Susheel Kumar, I.A.S. Joint Secretary, Ministry of Housing and Urban Poverty Alleviation Government of India 1.
Global Measles and Rubella Strategic Plan
The U.S. Presidents Emergency Plan for AIDS Relief Title The U.S Presidents Emergency Plan for AIDS Relief PEPFAR Male Circumcision Technical Working Group.
CHEMOPREVENTION FOR LIVER CANCER: MARKETING AND ETHICS
VISION: Preferred Partner for High Impact, Well-focused Development Assistance 1 The Medium Term Strategy – Progress and Challenges AfDB PARTNERSHIPS FORUM.
Pre Tender Meeting UNICEF Supply Division Copenhagen 10-11th December 2008 Siri Bjornstad Yellow Fever Vaccine Tender
The Millennium Development Goals Linkages with Child Health
1 Lincolnshire Research Observatory Lincolnshire’s Changing Population Components of Change and the Demographic Impact Eleanor.
Exploring Synergies Health Systems and Sustainability TB/HIV collaboration Alasdair Reid UNAIDS Pretoria International Multistakeholder Consultation on.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Selection of malaria treatments & diagnostics Presentation by Rémy Prohom RBM Partnership Secretariat, Malaria Medicines & Supplies Services Anglophone.
Pharmaceuticals and Global Health Inequalities and Innovation in the 21 st Century.
Kate Sweeney, HSE Chief Statistician
Evidence based use of Stats SA data for implementation of HIV&AIDS Program Ms Y.Tsibolane FS DoH, HIV and AIDS Program Date: October 2013.
Measles Outbreak. WHAT IS THIS PICTURE? Case Definition Clinical case definition – Any person in whom a clinician suspects measles infection – Any.
OPEN DAYS B11 Creating synergies between EU funds: demographic change and active ageing in European Territorial Cooperation and the ESF 9 October.
Employment Ontario Program Updates EO Leadership Summit – May 13, 2013 Barb Simmons, MTCU.
The Connecticut AIDS Residence Coalition, Inc. If only 100 people in CT had HIV/AIDS…
Greenspace and Wellbeing event 13 February 2008 Dr William Bird Strategic Health Advisor Natural England.
 Prevents 14 million cases of disease in the US each year  Objectives reflect a mobile world society  People continue to contract diseases that are.
Infant Young Child Feeding Symposium June 3, 2009 Atlanta, GA Helene D. Gayle, MD, MPH President and Chief Executive Officer CARE USA.
April 2014 The four health systems of the United Kingdom: how do they compare?
HIV/AIDS and Women: An Overview Global HIV/AIDS and Women: Current Challenges and Opportunities Briefing, Rayburn House Office Building Jen Kates, PhD.
What can Actavis contribute for the sustainability in the health care system?
Brazilian Social Entrepreneurship with a Chicago Flavor 04-Ago-14 dr.consulta/ Thomaz Srougi.
Institute for Public Health, Medical Decision Making and Health Technology Assessment 1 Results of the PanEuropean Hepatitis C Project 3 rd Paris Hepatitis.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Saving a Generation: Maternal, Newborn and Child Health (MNCH) Eastern and Southern Africa Aga Khan Health Services.
Towards an AIDS-Free Generation Women & Girls and HIV in PEPFAR
Working with communities to tackle malaria in Uganda HENRY TITO OKWALINGA PROJECT OFFICER, MALARIA, AMREF UGANDA.
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.
Malaria treatment policies: the challenge, strategies and the options SOTA, Nairobi, Kenya 12 th June 2002.
Roll Back Malaria: Why it has far failed? What should be done? Dr A Kochi Director, Global Malaria Programme WHO/Geneva.
Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
1 Ensuring medicines save lives: Facilitating access Defeating Malaria Together Jaya Banerji Director, Communications & Advocacy MMV.
MACDA U.S.A. Malaria Prevention Project 2015 by Claudia & Reuel.
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Presentation transcript:

The Novartis Malaria Initiative Der Weg zur Eliminierung von Malaria Silvio Gabriel, BASAID April 2012

Malaria is an African tragedy! More than 90% of malaria deaths occur in Africa 2/60a Malaria is preventable and treatable, yet nearly 655,000 lives are lost to the disease every year 2/73a Children under 5 years old and pregnant women are most at risk 1/2a Most of the older treatments (e.g. chloroquine) are not effective anymore because of resistance 3/14a Artemisinin-based Combination Therapies (ACTs) have transformed the treatment of malaria in the past decade Estimated incidence of malaria per 1,000 population in /221-2 Source: WHO Malaria Report >150 Data not available 2 | BASAID | Silvio Gabriel | April 2012 | Der Weg zur Eliminierung von Malaria | Business Use Only

The Novartis Malaria Initiative A holistic approach to best serve patients needs Capacity building – patient-focused education and information Best practice sharing workshops for public health officials responsible for malaria control State-of-the-art packaging and patient information developed specifically for not yet literate populations Training material made available free of charge in several local languages Access – affordability and availability are key Treatment provided without profit to governments and NGOs A 25-fold production increase since SMS for life: using mobile technology to help avoid stock-outs at health facility level 14/3a R&D – leading the path to malaria elimination Mass screening and targeted treatment of asymptomatic carriers 10/ 1a; 11/1a Next generation of malaria treatments 12/1179a/22 Treatment – Coartem ®, a story of firsts First fixed-dose ACT brought to market in 1999 and > 95% cure rate* with demonstrated safety profile 4/940a,b; 5/547a,b; 6/251a,254b; 7/246a; 8/1824a First ACT pre-qualified by the WHO for its efficacy, safety and quality 9/1a First dispersible sweet- tasting ACT specifically developed for infants and children 8/1820a * 28-day PCR-corrected in evaluable population 3 | BASAID | Silvio Gabriel | April 2012 | Der Weg zur Eliminierung von Malaria | Business Use Only

500 million Coartem ® treatments delivered Impacting more than 1 million lives Treatments in millions 84 Funding uncertain Global policy uncertain 125% 580% 7% 12% 14% Erratic orders Supply challenges ACT policy adoption ACT roll-out in public sector % Increase in production capacity (2001–2011) Deliveries 100 Success in patient impact results in mortality reduction Available production capacity Novartis Malaria Initiative | April %

Together with our partners, and with our continued patient-centric approach… 5 | BASAID | Silvio Gabriel | April 2012 | Der Weg zur Eliminierung von Malaria | Business Use Only

6

The Novartis Malaria Initiative Four pillars of activities 7 | BASAID | Silvio Gabriel | April 2012 | Der Weg zur Eliminierung von Malaria | Business Use Only

No one should die of malaria.